Sernova Corp.

Working to cure diabetes

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Sincerely,

George et al

Message: Resignation of Justin Leushner as President Board of Directors
Reply New Message
Back To Forum List View

Resignation of Justin Leushner as President Board of Directors

posted on Jan 21, 2009 01:17PM
January 21, 2009
Sernova Corp.: Resignation of Justin Leushner as President Board of Directors Initiates Internal Review
LONDON, ONTARIO--(Marketwire - Jan. 21, 2009) - Sernova Corp. (TSX VENTURE:SVA) -

Sernova Corp. announces that Justin Leushner, President of the Corporation since 2006, has resigned for personal reasons, effective January 31, 2009. Dr. George Adams, Chairman of the Board of Directors, said "On behalf of the shareholders and the Board of Directors, I would like to thank Justin for his leadership and hard work over the years, and wish him the best of luck in his future endeavours."

Prior to beginning a search for a new President, the Board of Directors has formed a subcommittee of the Board to conduct an internal review of the Corporation's research and development, financing and partnering activities and strategies. This subcommittee will be chaired by Mr. Jeffrey Bacha, an independent Director of the Corporation, who is presently Executive Vice President, Corporate Affairs and Chief Operating Officer of Clera Inc. of Vancouver, British Columbia. It is anticipated that this review will be completed in advance of the Corporation's Annual General Meeting which will be held in the spring of 2009.

About Sernova

Sernova Corp. is a Canadian-based, health-sciences company focused on commercializing medical technologies. Sernova is currently developing a platform technology for a number of serious disease indications, starting with a novel treatment for insulin-dependent diabetes, using its patented Sertolin cell technology. According to the American Diabetes Association approximately 9 million Americans require insulin injections and it is the sixth leading cause of death in the United States. One out of every 8 dollars spent on health care in the United States is spent on treating diabetes and its complications. Worldwide expenditures on insulin alone are estimated to be $15 billion annually and growing.
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply